Brava: Clinical Trials

1 trial sponsored by Brava, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Brava: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Nivolumab 40 mg in 4 ml Injection, Ipilimumab 200 MG in 40 ML Injection, Chemoradiation - Uterine Cervical Neoplasms
Phase 2RecruitingHospital Israelita Albert Einstein1122022-08-302024-01-05

Conditions studied

Uterine Cervical Neoplasms (1)

Interventions

Chemoradiotherapy (1)  ·  Injections (1)  ·  Ipilimumab (1)  ·  Nivolumab (1)

Countries

Brazil (1)

Top investigators

Fernando Maluf, MD (1)